Muhammad Abbasi is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Abbasi is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Colorectal Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, Childhood Iron Deficiency Anemia, and Bone Marrow Aspiration. Dr. Abbasi is currently accepting new patients.

Triple board-certified in internal medicine, hematology and medical oncology, Dr. Mohamad Cherry is medical director of Hematology at Atlantic Health System. He joins Atlantic Hematology Oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center, bringing years of clinical knowledge and expertise.With specialty training from some of the nation's most skilled clinicians, Dr. Cherry attained some of his clinical training at the leukemia department at MD Anderson and his fellowship in hematology/oncology from the University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He performed two residencies - an internal medicine residency at Staten Island University Hospital and a laboratory medicine residency at the American University of Beirut Medical Center in Lebanon. Previously, Dr. Cherry attained his medical degree at Lebanese University and performed his internship at Sacre Coeur Hospital-Lebanese University. He also earned a master of science degree in clinical and translational research from University of Oklahoma College of Public Health.Dr. Cherry remains on staff as clinical associate professor of hematology/oncology at University of Oklahoma Health Sciences Center's Stephenson Cancer Center. He is also the director of its hematology/oncology fellowship program and co-chairs the Academy of Teaching Scholars Faculty Development, Education and Mentoring Committee. Other administrative roles include co-chair of the leukemia working group at the Sarah Cannon Research Institute Blood Cancer Consortium.As a principal investigator of multiple clinical trials, Dr. Cherry has performed groundbreaking research in niche areas that include epigenetics and development of new therapeutics in relapsed and refractory blood cancers. He has developed teaching materials and book chapters, and has lectured both nationally and internationally.Dr. Cherry continues to serves as a mentor and an advisor to fellows, residents and medical students. He contributes to continuing education, public health, and professional development, and has won awards and funding for both his research and his clinical pursuits. Dr. Cherry is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, Midline Lethal Granuloma, and Bone Marrow Aspiration.

An expert in cancer care, Dr. Ellen Early brings broad-based knowledge and expertise to Atlantic Medical Group. She joins Atlantic Hematology Oncology, a growing team that is housed at Carol G. Simon Cancer Center at Morristown Medical Center. Board certified in internal medicine and medical oncology, Dr. Early diagnoses and treats cancer patients using a multidisciplinary approach, which includes radiation and surgical oncology and incorporates clinicians who work collaboratively to deliver the highest quality cancer care possible. In practice for over 25 years, Dr. Early has particular interest in caring for people with breast and lung cancers. Regarded by patients, families and colleagues for both her expertise and her compassion, Dr. Early strives to educate patients about their condition and discuss how to choose the best individualized treatment plan. Passionate about research, Dr. Early has participated in clinical trials throughout her professional career and utilizes chemotherapies, medications and targeted modalities to treat cancers of the breast and lung. After graduating from Saint Peter's University with a bachelor's of science in Biology, Dr. Early went on to achieve her master's degree in molecular biology at City University of New York in Brooklyn. She attended Georgetown University School of Medicine and performed both her internal medicine residency and her fellowship training in hematology and oncology at Memorial Sloan Kettering Cancer Center. Dr. Early is rated as an Advanced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Advanced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration.

Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is rated as an Advanced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration.

Joshua A. Strauss, MD, is a hematologist-oncologist with Advanced Care Oncology and Hematology Associates (ACOHA), part of the Atlantic Medical Group (AMG). He is fellowship-trained and double-board-certified in medical oncology and hematology by the American Board of Internal Medicine. He has more than 15 years of experience taking care of patients with a variety of malignancies and blood disorders. Dr. Strauss especially takes pride in treating his patients with compassion and going the extra mile to deliver the highest quality of care.Dr. Strauss strives to incorporate the most up-to-date knowledge in the field with an approach geared to the needs of each individual patient. He maintains clinical interests in gastrointestinal, urologic and gynecologic cancers, as well as leukemia, lymphoma and benign blood disorders. Dr. Strauss joined ACOHA in 2015.After earning his medical degree at the Albert Einstein College of Medicine in the Bronx, where he graduated with special distinction for research in medical oncology, Dr. Strauss completed his residency in internal medicine at New York University Langone Medical Center. He then completed fellowship training in hematology/oncology at New York-Presbyterian/Columbia University Medical Center, also in NYC, where he participated in high-level research and published several peer-reviewed articles in gastrointestinal cancer.Dr. Strauss has been voted by physician colleagues as a “Top Doctor” in New Jersey Monthly magazine every year since 2020. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Strauss is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Colorectal Cancer, and Bone Marrow Aspiration.

Karleung Siu is a Hematologist and an Oncologist in Florham Park, New Jersey. Dr. Siu is rated as an Advanced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Anemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Siu is currently accepting new patients.

David Gallinson is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Gallinson is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Familial Colorectal Cancer, Anemia, Paget Disease of the Breast, Breast Cancer, and Bone Marrow Aspiration. Dr. Gallinson is currently accepting new patients.

Dual board-certified in hematology and medical oncology, Dr. Gupta brings over a decade of clinical and research experience and expertise to Atlantic Medical Group. Dr. Gupta works closely with multidisciplinary groups in diagnosis and management of early stage and advanced breast cancers, and cancers of the head and neck area. She closely collaborates with physicians in surgical oncology and radiation oncology to deliver outstanding care to her patients and their family. She also treats benign hematology disorders such as anemia, and other blood abnormalities.Dr. Gupta completed her medical school at one of the best institutions in India and then went on to complete her internal medicine residency and hematology and oncology fellowship at Staten Island University Hospital, Northwell Health. After completing her education, she served as Assistant Professor of Medicine at Northwell Health System in Staten Island. She was also faculty member at State University of New York (SUNY Downstate) during her association with Staten Island Hospital. She subsequently joined the faculty at Weill Cornell Medical Center, New York Presbyterian Hospital, where she continued her commitment to excellent patient care.Dr. Gupta is also an active volunteer for the American Society of Clinical Oncology (ASCO), and continues to participate in various endeavors towards improvement in cancer care at a global level. She is widely published, and has won awards for her research and publications. She continues to actively enroll patients in breast oncology and head and neck oncology and serves as the principal investigator for several clinical trials within Atlantic Health System.Dr. Gupta is also the Associate Program Director of the Hematology and Oncology Fellowship Program at Atlantic Health System, and continues to mentor and train residents and fellows.Fluent in English and Hindi, Dr. Gupta is part of Atlantic Medical Group and a participating provider of the Atlantic Accountable Care Organization. Dr. Gupta is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Thrombocytopenia.

Michael Wax is a Hematologist and an Oncologist in Berkeley Heights, New Jersey. Dr. Wax is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Non-Hodgkin Lymphoma, Myelodysplastic Syndrome (MDS), Gastric Lymphoma, and Polycythemia Vera. Dr. Wax is currently accepting new patients.

Anisha Rodrigues is a primary care provider, practicing in Internal Medicine in Florham Park, New Jersey. Dr. Rodrigues is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and Hypothyroidism. Dr. Rodrigues is currently accepting new patients.

Zhexiang Li is a primary care provider, practicing in Internal Medicine in Florham Park, New Jersey. Dr. Li is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Hypertension, and Idiopathic Edema. Dr. Li is currently accepting new patients.

Jeanette Kovtun is an Internal Medicine provider in Florham Park, New Jersey. Dr. Kovtun is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Mesothelioma, Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, and Thrombocytopenia. Dr. Kovtun is currently accepting new patients.

Roshini George is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. George is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Myelodysplastic Syndrome (MDS), and Immune Thrombocytopenic Purpura (ITP). Dr. George is currently accepting new patients.

William Derosa is a Hematologist and an Oncologist in Morristown, New Jersey. Dr. Derosa is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Plasmacytoma, Small Lymphocytic Lymphoma (SLL), Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, and Bone Marrow Aspiration. Dr. Derosa is currently accepting new patients.

Charlesse Pondt-Huannou, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Board-certified in medical oncology and hematology by the American Board of Internal Medicine, she has more than 15 years of experience treating blood diseases and various forms of cancer. Dr. Pondt-Huannou is dedicated to providing the highest quality of care for her patients. She listens thoroughly and takes time to carefully explain everything involved in the patient’s individualized plan of care.Dr. Pondt-Huannou is an expert in the fields of breast and gynecological cancers; hematologic malignancies (myeloma and chronic leukemias and lymphomas); managing complex hematological issues in high-risk obstetric and gynecologic patients; sickle cell disease; and anemia. She is also experienced in the management of liver, bladder, colon, cervical, lung, prostate and pancreatic cancers. She joined ACOHA immediately out of fellowship in 2014.After earning her medical degree from UMDNJ New Jersey Medical School in Newark, NJ, Dr. Pondt-Huannou completed an internal medicine residency at Memorial Sloan-Kettering Cancer Center concurrent with a residency at New York-Presbyterian, Cornell Medical Center, both in New York City. She completed a hematology and oncology fellowship at Albert Einstein College/Montefiore and Jacobi medical centers and Lincoln Hospital in the Bronx, NY.Dr. Pondt-Huannou is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Medical Association, and the National Medical Association. She also serves on numerous committees including the Sickle Cell Management Committee at Overlook Medical Center. She is a participating provider of the Atlantic Accountable Care Organization. Dr. Huannou is rated as an Advanced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Childhood Iron Deficiency Anemia, Anemia, Deep Vein Thrombosis, and Myelodysplastic Syndrome (MDS).

Jason Levitz is a Hematologist and an Oncologist in Denville, New Jersey. Dr. Levitz is rated as an Advanced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Polycythemia Vera, Colorectal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Levitz is currently accepting new patients.

Adhithaselvi Elango is a primary care provider, practicing in Internal Medicine in Livingston, New Jersey. Dr. Elango is rated as an Advanced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Sepsis, Autosomal Dominant Partial Epilepsy with Auditory Features, Memory Loss, Gastrostomy, and Bone Marrow Aspiration.

Anthony Cioce is a primary care provider, practicing in Family Medicine in Morristown, New Jersey. Dr. Cioce is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Middle East Respiratory Syndrome (MERS), Homocystinuria, Methylmalonic Acidemia with Homocystinuria, and Inborn Amino Acid Metabolism Disorder. Dr. Cioce is currently accepting new patients.

Raunaq Bhatt is a primary care provider, practicing in Hospital Medicine in Morristown, New Jersey. Dr. Bhatt is rated as an Experienced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Large-Cell Immunoblastic Lymphoma, Bone Marrow Aspiration, and Gastrostomy.